Effect of Community‐Wide Conjugate Pneumococcal Vaccine Use in Infancy on Nasopharyngeal Carriage through 3 Years of Age: A Cross‐Sectional Study in a High‐Risk Population | Zendy

Eugene V. Millar | Zendy; Katherine L. O’Brien | Zendy; James Watt | Zendy; Melinda A. Bronsdon | Zendy; Jean H. Dallas | Zendy; Cynthia G. Whitney | Zendy; Raymond Reid | Zendy; Mathuram Santosham | Zendy

Open Access

Effect of Community‐Wide Conjugate Pneumococcal Vaccine Use in Infancy on Nasopharyngeal Carriage through 3 Years of Age: A Cross‐Sectional Study in a High‐Risk Population

Author(s) -

Eugene V. Millar,

Katherine L. O’Brien,

James Watt,

Melinda A. Bronsdon,

Jean H. Dallas,

Cynthia G. Whitney,

Raymond Reid,

Mathuram Santosham

Publication year - 2006

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/504802

Subject(s) - medicine , carriage , pneumococcal conjugate vaccine , vaccination , population , conjugate vaccine , streptococcus pneumoniae , pediatrics , pneumococcal infections , meningococcal vaccine , serotype , immunology , immunization , antibiotics , antibody , microbiology and biotechnology , environmental health , pathology , biology

A 7-valent pneumococcal conjugate vaccine (PnCRM7) has been shown to be highly effective in preventing invasive pneumococcal disease. Pneumococcal conjugate vaccines also protect against nasopharyngeal carriage of vaccine serotypes, but the duration of protection against nasopharyngeal carriage is not known.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research